All Pharma News
PolarityTE Announces First Subject Screened in Phase III Study Evaluating SkinTE

PolarityTE Announces First Subject Screened in Phase III Study Evaluating SkinTE
GLOBENEWSWIRE
26 Feb 2024
Share Share
PolarityTE Confirms Receipt of Unsolicited Offer to Acquire the Company

PolarityTE Confirms Receipt of Unsolicited Offer to Acquire the Company
BIOSPACE
09 Nov 2022
Share Share
PolarityTE Reports Q2 2022 Rusult and Provides Business Update

PolarityTE Reports Q2 2022 Rusult and Provides Business Update
PRNEWSWIRE
11 Aug 2022
Share Share
PolarityTE Reports First Quarter 2022 Financial Results

PolarityTE Reports First Quarter 2022 Financial Results
PRNEWSWIRE
16 May 2022
Share Share
PolarityTE Bags FDA RMAT Designation Granted to SkinTE

PolarityTE Bags FDA RMAT Designation Granted to SkinTE
PRNEWSWIRE
13 May 2022
Share Share
PolarityTE Submits Complete Response to FDA`s Clinical Hold for SkinTE IND

PolarityTE Submits Complete Response to FDA`s Clinical Hold for SkinTE IND
PRNEWSWIRE
20 Dec 2021
Share Share
PolarityTE Provides Update on Investigational New Drug Application

PolarityTE Provides Update on Investigational New Drug Application
PRNEWSWIRE
07 Oct 2021
Share Share
PolarityTE makes CEO and CMO appointments

PolarityTE makes CEO and CMO appointments
SEEKING ALPHA
02 Sep 2021
Share Share
Manufacturing issues force PolarityTE to halt skin repair IND

Manufacturing issues force PolarityTE to halt skin repair IND
Kevin Dunleavy FIERCEPHARMA
24 Aug 2021
Share Share
PolarityTE stock tanks 19% on FDA clinical hold for SkinTE application

PolarityTE stock tanks 19% on FDA clinical hold for SkinTE application
BUSINESSWIRE
24 Aug 2021
Share Share